ClinConnect ClinConnect Logo
Search / Trial NCT06871891

Effect of Perioperative Sleep Quality on Chronic Post-Surgical Pain

Launched by PEKING UNION MEDICAL COLLEGE HOSPITAL · Mar 7, 2025

Trial Information

Current as of April 22, 2025

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Aged 18-80 years.
  • 2. Scheduled for elective video-assisted thoracic surgery (VATS).
  • 3. Scheduled for elective modified radical mastectomy (MRM).
  • 4. Scheduled for elective coronary artery bypass grafting (CABG).
  • 5. American Society of Anesthesiologists (ASA) physical status classification I-III.
  • 6. Willing to sign the informed consent form, participate in the study, and complete all follow-up assessments.
  • Exclusion Criteria:
  • 1. History of surgery within the past 3 months.
  • 2. Chronic use of opioids or sedatives (defined as use for 3 months or longer).
  • 3. Expected completion time of surgery after 16:00 on the day of operation.
  • 4. Planned transfer to the intensive care unit (ICU) postoperatively.
  • 5. Anticipated hospital stay \<24 hours.
  • 6. Contraindications to wearable device use (e.g., infection at the wrist site, allergy to the wristband material).

About Peking Union Medical College Hospital

Peking Union Medical College Hospital (PUMCH) is a prestigious medical institution and a leading research facility located in Beijing, China. Affiliated with the Chinese Academy of Medical Sciences, PUMCH is renowned for its commitment to advancing healthcare through innovative clinical research and high-quality patient care. The hospital plays a pivotal role in the development and execution of clinical trials across various medical disciplines, focusing on improving treatment outcomes and enhancing medical knowledge. With a multidisciplinary team of experts and state-of-the-art facilities, PUMCH is dedicated to contributing to global health advancements and fostering collaborations in the medical research community.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported